Skip to main content

Recursion Pharmaceuticals, Inc.

RXRX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001601830

In the last 90 days, Recursion Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 4 sales; 344 institutions reported holding it in 13F filings for Q2 2026, worth $1.33B in total; ARK Invest is the only superinvestor holding it.

13F holders, Q2 2025

Institutional positions in Recursion Pharmaceuticals, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
333
−3 vs. Q1 2025
Shares held
310.3M
+2.62M (+0.9%) vs. Q1 2025
Total value
$1.57B
−$57.8M (−3.5%) vs. Q1 2025
New holders
56
112 more added
Sold out
59
89 more reduced

1 institution that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q1 2025: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting RXRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2025: 333 institutions
Q1 2021: 1 institutionQ2 2021: 75 institutionsQ3 2021: 84 institutionsQ4 2021: 126 institutionsQ1 2022: 128 institutionsQ2 2022: 133 institutionsQ3 2022: 146 institutionsQ4 2022: 144 institutionsQ1 2023: 159 institutionsQ2 2023: 158 institutionsQ3 2023: 192 institutionsQ4 2023: 199 institutionsQ1 2024: 248 institutionsQ2 2024: 270 institutionsQ3 2024: 268 institutionsQ4 2024: 316 institutionsQ1 2025: 337 institutionsQ2 2025: 333 institutionsQ3 2025: 322 institutionsQ4 2025: 335 institutionsQ1 2026: 335 institutionsQ2 2026: 344 institutions
Value heldQ2 2025: $1.57B
Q1 2021: $1.00KQ2 2021: $1.71BQ3 2021: $1.26BQ4 2021: $1.62BQ1 2022: $680.3MQ2 2022: $861.1MQ3 2022: $1.21BQ4 2022: $954.0MQ1 2023: $841.4MQ2 2023: $952.8MQ3 2023: $1.16BQ4 2023: $2.04BQ1 2024: $2.12BQ2 2024: $1.89BQ3 2024: $1.74BQ4 2024: $2.06BQ1 2025: $1.63BQ2 2025: $1.57BQ3 2025: $1.58BQ4 2025: $1.33BQ1 2026: $1.03BQ2 2026: $1.33B
Institutions holding RXRX and their total value by quarter
QuarterHoldersValue
Q2 2026344$1.33B
Q1 2026335$1.03B
Q4 2025335$1.33B
Q3 2025322$1.58B
Q2 2025333$1.57B
Q1 2025337$1.63B
Q4 2024316$2.06B
Q3 2024268$1.74B
Q2 2024270$1.89B
Q1 2024248$2.12B
Q4 2023199$2.04B
Q3 2023192$1.16B
Q2 2023158$952.8M
Q1 2023159$841.4M
Q4 2022144$954.0M
Q3 2022146$1.21B
Q2 2022133$861.1M
Q1 2022128$680.3M
Q4 2021126$1.62B
Q3 202184$1.26B
Q2 202175$1.71B
Q1 20211$1.00K

Institutions, Q2 2025

Shares, value and share of portfolio for each institution holding Recursion Pharmaceuticals, Inc.; share changes are against Q1 2025.

Institutions holding RXRX in Q2 2025
InstitutionSharesValue% of portfolioChange in sharesAction
Jump Financial, LLC1,151,201$5.83M0.07%+558,848+94.3%Added
Barclays PLC1,164,689$5.89M0.00%+573,683+97.1%Added
Two Sigma Investments, LP1,167,813$5.91M0.01%+15,187+1.3%Added
Nuveen, LLC1,225,658$6.20M0.00%−686,962−35.9%Reduced
Citadel Advisors LLC1,314,552$6.65M0.01%−1,341,159−50.5%Reduced
Vestmark Advisory Solutions, Inc.1,339,139$6.78M0.10%+632,900+89.6%Added
Bank of America Corp1,378,915$6.98M0.00%+93,953+7.3%Added
First Trust Advisors LP1,880,290$9.51M0.01%+848,791+82.3%Added
Charles Schwab Investment Management Inc2,589,202$13.1M0.00%+310,801+13.6%Added
Northern Trust Corp2,914,872$14.7M0.00%+519,684+21.7%Added
Norges Bank3,169,938$16.0M0.00%−242,065−7.1%Reduced
Susquehanna International Group, LLP3,205,339$16.2M0.02%+1,155,728+56.4%Added
Exor Capital LLP3,675,077$18.6M0.40%00.0%Unchanged
DCVC Opportunity Fund II GP, LLC3,951,141$20.0M17.35%00.0%Unchanged
UBS Asset Management Americas Inc4,615,516$23.4M0.00%−1,793,008−28.0%Reduced
UBS Group AG4,630,590$23.4M0.00%−939,192−16.9%Reduced
FMR LLC5,584,858$28.3M0.00%−1,261,984−18.4%Reduced
Morgan Stanley5,689,612$28.8M0.00%+679,179+13.6%Added
Data Collective IV GP, LLC5,941,120$30.1M23.14%00.0%Unchanged
NVIDIA Corp7,706,363$39.0M0.90%00.0%Unchanged
Geode Capital Management, LLC7,776,408$39.4M0.00%+1,332,428+20.7%Added
Nikko Asset Management Americas, Inc.8,167,745$41.2M0.41%−239,589−2.8%Reduced
Sumitomo Mitsui Trust Holdings, Inc.8,167,745$41.3M0.03%−311,539−3.7%Reduced
MIC Capital Management UK LLP9,644,032$48.8M9.58%00.0%Unchanged
Novo Holdings A/S9,665,128$48.9M3.45%00.0%Unchanged
State Street Corp11,179,539$56.6M0.00%−1,905,719−14.6%Reduced
Mubadala Investment Co PJSC12,985,927$65.7M0.35%00.0%Unchanged
Kinnevik AB (publ)13,434,171$68.0M100.00%00.0%Unchanged
Softbank Group Corp14,667,491$74.2M0.30%00.0%Unchanged
Baillie Gifford & Co24,173,815$122.3M0.09%−219,200−0.9%Reduced
BlackRock, Inc.28,371,063$143.6M0.00%+4,864,474+20.7%Added
ARK Investment Management LLCSuperinvestorARK Invest32,988,631$166.9M1.22%−1,826,871−5.2%Reduced
Vanguard Group Inc36,071,178$182.5M0.00%+3,783,201+11.7%Added
Laurion Capital Management LP0$00.00%−1,547,407−100.0%Sold out
Balyasny Asset Management LLC0$00.00%−652,644−100.0%Sold out
Simplex Trading, LLC0$00.00%−481,048−100.0%Sold out
Platinum Investment Management Ltd0$00.00%−395,954−100.0%Sold out
IMC-Chicago, LLC0$00.00%−183,040−100.0%Sold out
Qube Research & Technologies Ltd0$00.00%−172,349−100.0%Sold out
Corebridge Financial, Inc.0$00.00%−123,182−100.0%Sold out
Oracle Investment Management Inc0$00.00%−120,000−100.0%Sold out
Wesbanco Bank Inc0$00.00%−112,517−100.0%Sold out
D.A. Davidson & Co.0$00.00%−107,432−100.0%Sold out
Nebula Research & Development LLC0$00.00%−101,623−100.0%Sold out
Two Sigma Advisers, LP0$00.00%−95,445−100.0%Sold out
Avanza Fonder AB0$00.00%−86,342−100.0%Sold out
Fox Run Management, L.L.C.0$00.00%−59,525−100.0%Sold out
Cito Capital Group, LLC0$00.00%−52,000−100.0%Sold out
SIH Partners, LLLP0$00.00%−51,202−100.0%Sold out
Gsa Capital Partners LLP0$00.00%−30,153−100.0%Sold out
New Republic Capital, LLC0$00.00%−28,046−100.0%Sold out
Syon Capital LLC0$00.00%−22,150−100.0%Sold out
Quantinno Capital Management LP0$00.00%−19,296−100.0%Sold out
Fullcircle Wealth LLC0$00.00%−17,405−100.0%Sold out
Change Path, LLC0$00.00%−18,935−100.0%Sold out
DnB Asset Management AS0$00.00%−18,917−100.0%Sold out
Exchange Traded Concepts, LLC0$00.00%−18,624−100.0%Sold out
DBK Financial Counsel, LLC0$00.00%−15,000−100.0%Sold out
SummitTX Capital, L.P.0$00.00%−14,620−100.0%Sold out
Ground Swell Capital, LLC0$00.00%−14,553−100.0%Sold out
Baird Financial Group, Inc.0$00.00%−14,498−100.0%Sold out
NFP Retirement, Inc.0$00.00%−13,254−100.0%Sold out
Farringdon Capital, Ltd.0$00.00%−12,582−100.0%Sold out
FORA Capital, LLC0$00.00%−12,467−100.0%Sold out
Ci Investments Inc.0$00.00%−11,874−100.0%Sold out
111 Capital0$00.00%−11,480−100.0%Sold out
Universal- Beteiligungs- und Servicegesellschaft mbH0$00.00%−10,829−100.0%Sold out
Vident Advisory, LLC0$00.00%−10,125−100.0%Sold out
GWN Securities Inc.0$00.00%−10,411−100.0%Sold out
Aster Capital Management (DIFC) Ltd0$00.00%−2,377−100.0%Sold out
JNBA Financial Advisors0$00.00%−2,450−100.0%Sold out
Amundi0$00.00%−2,401−100.0%Sold out
Twin Tree Management, LP0$00.00%−1,836−100.0%Sold out
Ronald Blue Trust, Inc.0$00.00%−1,382−100.0%Sold out
Comprehensive Financial Planning, Inc.0$00.00%−1,159−100.0%Sold out
Coldstream Capital Management Inc0$00.00%−889−100.0%Sold out
Close Asset Management Ltd0$00.00%−800−100.0%Sold out
Proffitt & Goodson Inc0$00.00%−657−100.0%Sold out
True Wealth Design, LLC0$00.00%−485−100.0%Sold out
ORG Partners LLC0$00.00%−468−100.0%Sold out
Parallel Advisors, LLC0$00.00%−393−100.0%Sold out
Cordant, Inc.0$00.00%−389−100.0%Sold out
Golden State Wealth Management, LLC0$00.00%−385−100.0%Sold out
Decker Retirement Planning Inc.0$00.00%−300−100.0%Sold out
Boston Private Wealth LLC0$00.00%−264−100.0%Sold out
Hazlett, Burt & Watson, Inc.0$00.00%−150−100.0%Sold out
Fifth Third Bancorp0$00.00%−146−100.0%Sold out
DAGCO, Inc.0$00.00%−100−100.0%Sold out
SJS Investment Consulting Inc.0$00.00%−100−100.0%Sold out
WealthTrak Capital Management LLC0$00.00%−15−100.0%Sold out
TFC Financial Management0$00.00%−1−100.0%Sold out
Avion Wealth0$00.00%−84−100.0%Sold out
Lindbrook Capital, LLC––––Not filed